RxDoctor Payments Data

Constantine Demetracopoulos, MD

Foot and Ankle Surgery · New York, NYNPI 1346417805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $661,125 of the $888,116 with a category attached, or 74.4%. Exactech, Inc. accounts for 68.2% of it on its own, with 23 other manufacturers making up the rest. Among foot and ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$888,116in general payments, 2019–2025

Across 630 payments — averaging $1409.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$606K
  • Arthrex$167K
  • Stryker$23K
  • Treace Medical Concepts, Inc.$15K
  • Responsive Arthroscopy Inc$14K
  • Medshape, Inc.$12K
  • plus $51K from 18 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$250

What the payments were for

  • Royalty or licence$39,3844%
  • Consulting fees$661,12574%
  • Speaking & faculty fees$89,47510%
  • Grants$8,5081%
  • Travel & lodging$73,3858%
  • Food & beverage$16,2392%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exactech, Inc.364$606,097
Arthrex114$166,955
Stryker(2 entities)46$22,691
Treace Medical Concepts, Inc.16$15,132
Responsive Arthroscopy Inc13$14,230
Medshape, Inc.18$11,838
Paragon 28, Inc.10$11,300
DJO, LLC1$8,508
Royal Biologics, Inc.8$4,994
Surgalign Spine Technologies, Inc.2$4,775
Restor3d, Inc.4$4,239
Linvatec Corporation11$4,109
Encore Medical, LP2$3,906
In2bones USA, LLC6$3,490
Integra Lifesciences Corporation4$2,101
Pioneer Surgical Technology, Inc.1$1,500
Suvon Surgical LLC3$863
Trilliant Surgical LLC.1$750
Novastep Inc.1$191
Acumed LLC1$150
Lightbody Medical Technologies Inc1$122
Tricoast Surgical Solutions LLC1$120
Pacira Pharmaceuticals Incorporated1$35
Fidia Pharma USA Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$888,116 in reported general payments places this provider in the 95th percentile of 652 foot and ankle surgery providers in New York.

See all foot and ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$143,448
Medicare patients
351
Services billed
673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib12$737
Meloxicam19$55

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →